Monitor for a Form 4 filing to confirm whether the sale was executed. The proposed amount (~$908K) is modest relative to market cap, so the signal is weak. However, as an officer sale, it warrants attention for any pattern of insider distribution ahead of upcoming catalysts or earnings.
Price Chart
Executive Summary
Jason V. Coloma, an officer of Maze Therapeutics, filed a Form 144 to sell 34,501 shares of common stock, with an estimated aggregate market value of approximately $908,066. The shares are held across two trusts and were acquired through gifts and prior transactions dating back to 2018 and 2019. This is an advance notice of intent to sell, not a completed sale, but the filing signals an insider's consideration of monetizing a significant position.
Key Facts
- Officer Jason V. Coloma filed Form 144 to sell 34,501 shares of Maze Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is approximately $908,066.
- Shares are held by The Coloma 2021 Irrevocable Trust and Coloma Family Trust, acquired via gifts in 2018 and 2019.
- The filing is an advance notice of intent to sell, not a completed transaction.
Financial Impact
Proposed sale of 34,501 shares valued at ~$908,066, representing a small fraction of the company's $1.5B market cap.
Risk Factors
- The sale may not be completed; Form 144 is only an intent to sell.
- If executed, it could signal insider distribution, though the dollar amount is small relative to market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001969223-26-000973 |
| Document: 0001969223-26-000973-index.html | 0001969223-26-000973 |
| Document: 0001969223-26-000973.txt | 0001969223-26-000973 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 2, 2026 29d ago | 144 | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 1, 2026 4w ago | 144 | $26.72 $24.82 | ▼ −7.11% | ▼ −6.15% | $26.69 (−0.12%) |
Aug 17, 2026 6w ago | 3 | $29.13 $30.42 | ▲ +4.43% | ▲ +4.63% | $26.69 (−8.38%) |
Aug 11, 2026 7w ago | Press Release | $27.53 $29.75 | ▲ +8.06% | ▲ +8.51% | $26.69 (−3.06%) |
Aug 7, 2026 8w ago | Institutional Cluster | $28.65 $27.18 | ▼ −5.13% | ▼ −5.53% | $26.69 (−6.85%) |
Aug 5, 2026 8w ago | Insider Cluster | $27.81 $27.53 | ▼ −1.01% | ▼ −1.36% | $26.69 (−4.04%) |
Jul 2, 2026 13w ago | Insider Cluster | $31.26 $32.42 | ▲ +3.71% | ▲ +2.78% | $26.69 (−14.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access